10X Fund, L.P. - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
10X Fund, L.P. is an investment firm tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $2.43M.
Profile
10X Fund, L.P. is an investment firm that reports beneficial ownership of shares in GALECTIN THERAPEUTICS INC (GALT) under U.S. securities law. It has submitted 23 SEC insider filings since 2025, most recently in December 2025.
| Filer type | Fund |
|---|---|
| Role | 10% Owner |
| Notability | 20/100 |
Board memberships
- GALECTIN THERAPEUTICS INC
Reported roles
- 10% Owner
Trading Pattern
InsiderAlpha's records for 10X Fund, L.P. go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role 10X Fund, L.P. has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- 10% Owner at GALECTIN THERAPEUTICS INC (GALT) - 5 filings, 2025
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-18 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale | 30.7K | $6.66 | $204K |
| 2025-12-18 | GALT | GALECTIN THERAPEUTICS INC | J - Other acquisition / disposition | 24.0K | - | |
| 2025-12-08 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale | 132.1K | $5.73 | $757K |
| 2025-12-08 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale | 30.0K | $5.47 | $164K |
| 2025-12-04 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale | 120.0K | $5.73 | $688K |
| 2025-12-04 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale | 30.0K | $5.47 | $164K |
| 2025-11-12 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale | 40.0K | $5.25 | $210K |
| 2025-10-24 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale | 30.0K | $4.94 | $148K |
| 2025-10-24 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale | 20.0K | $4.93 | $99K |
Most Active Insiders Right Now
10X Fund, L.P. has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- A.L. Sarroff Fund, LLC
- ABRAMS CAPITAL MANAGEMENT, L.P.
- Abu Dhabi Investment Authority
- Abu Dhabi Pension Fund
- William A. Ackman
- AEI Capital Ltd
- Noubar Afeyan
- Behzad Aghazadeh
Frequently Asked Questions
What is 10X Fund, L.P.?
10X Fund, L.P. is an investment firm that reports beneficial ownership of shares in GALECTIN THERAPEUTICS INC (GALT) under U.S. securities law. It has submitted 23 SEC insider filings since 2025, most recently in December 2025.…
Has 10X Fund, L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.43M) across all tracked filings.
Where can I see all of 10X Fund, L.P.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live 10X Fund, L.P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.